Pluristem Therapeutics Inc PSTI
We take great care to ensure that the data presented and summarized in this overview for PLURISTEM THERAPEUTICS INC is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in PSTI
Top Purchases
Top Sells
About PSTI
Insider Transactions at PSTI
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 04
2025
|
Zami Aberman Director |
BUY
Grant, award, or other acquisition
|
Direct |
346
+0.24%
|
-
|
|
Dec 04
2025
|
Maital Shemesh Rasmussen Director |
BUY
Grant, award, or other acquisition
|
Direct |
699
+3.52%
|
-
|
|
Dec 04
2025
|
Liat Zalts Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,660
+3.8%
|
-
|
|
Dec 04
2025
|
Rami Avraham Levi Director |
BUY
Grant, award, or other acquisition
|
Direct |
653
+3.33%
|
-
|
|
Dec 04
2025
|
Yaky Yanay Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,588
+1.31%
|
-
|
|
Dec 04
2025
|
Eitan Ajchenbaum Director |
BUY
Grant, award, or other acquisition
|
Direct |
668
+5.13%
|
-
|
|
Dec 04
2025
|
Alexandre Weinstein Manieu Director |
BUY
Grant, award, or other acquisition
|
Direct |
519
+4.6%
|
-
|
|
Nov 12
2025
|
Eitan Ajchenbaum Director |
BUY
Grant, award, or other acquisition
|
Direct |
11,685
+50.0%
|
-
|
|
Oct 29
2025
|
Alexandre Weinstein Manieu Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
1,002,169
+34.14%
|
-
|
|
Oct 15
2025
|
Yaky Yanay Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
39,050
+7.36%
|
-
|
|
Apr 28
2025
|
Alexandre Weinstein Manieu Director |
BUY
Open market or private purchase
|
Indirect |
1,428,841
+45.33%
|
$5,715,364
$4.61 P/Share
|
|
Apr 28
2025
|
Alexandre Weinstein Manieu Director |
SELL
Other acquisition or disposition
|
Indirect |
976,139
-51.18%
|
-
|
|
Feb 25
2025
|
Alexandre Weinstein Manieu Director |
BUY
Grant, award, or other acquisition
|
Direct |
20,500
+50.0%
|
-
|
|
Feb 25
2025
|
Pinhas Doron Birger Director |
BUY
Grant, award, or other acquisition
|
Direct |
11,685
+37.86%
|
-
|
|
Feb 25
2025
|
Yaky Yanay Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
181,900
+28.69%
|
-
|
|
Feb 25
2025
|
Zami Aberman Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,350
+9.07%
|
-
|
|
Feb 25
2025
|
Liat Zalts Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
67,857
+43.23%
|
-
|
|
Feb 25
2025
|
Maital Shemesh Rasmussen Director |
BUY
Grant, award, or other acquisition
|
Direct |
11,173
+37.72%
|
-
|
|
Feb 25
2025
|
Rami Avraham Levi Director |
BUY
Grant, award, or other acquisition
|
Direct |
11,173
+37.89%
|
-
|
|
Sep 18
2024
|
Chen Franco Yehuda Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,413
+11.08%
|
-
|
Last 12 Months Summary
Buy / Acquisition
2.81M
Shares
From
10
Insiders
| Grant, award, or other acquisition | 383K shares |
|---|---|
| Exercise of conversion of derivative security | 1M shares |
| Open market or private purchase | 1.43M shares |
Sell / Disposition
976K
Shares
From
1
Insiders
| Other acquisition or disposition | 976K shares |
|---|